KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Accured Expenses (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Change in Accured Expenses for 8 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 65.96% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $870000.0 through Dec 2025, down 75.9% year-over-year, with the annual reading at $870000.0 for FY2025, 75.9% down from the prior year.
  • Change in Accured Expenses hit $1.7 million in Q4 2025 for Castle Biosciences, down from $6.8 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $13.6 million in Q2 2023 to a low of -$14.7 million in Q1 2025.
  • Historically, Change in Accured Expenses has averaged $593200.0 across 5 years, with a median of $51000.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 39968.97% in 2023 and later surged 142420.0% in 2025.
  • Year by year, Change in Accured Expenses stood at $3.2 million in 2021, then plummeted by 103.44% to -$110000.0 in 2022, then soared by 793.64% to $763000.0 in 2023, then soared by 539.97% to $4.9 million in 2024, then crashed by 65.96% to $1.7 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CSTL at $1.7 million in Q4 2025, $6.8 million in Q3 2025, and $7.1 million in Q2 2025.